PCF Webinar Series Continues in 2023

Our educational webinar series continues in 2023, hosted by PCF CEO Charles J. Ryan, MD.

PCF aims to connect patients and caregivers with current, essential information across the various stages of the prostate cancer journey. Each month, Dr. Ryan will speak with leaders in the field of prostate cancer diagnosis, treatment, research, and survivorship and answer your questions during these live virtual events.

Webinars are FREE and open to ALL.

May 16, 2023: Genetic and Biomarker Testing: What Does It Mean for Me?

Time: 4:30 PM Pacific / 7:30 PM Eastern

Genetic testing and biomarker testing can help doctors and patients learn as much as possible about each patient’s prostate cancer. People across all stages of the prostate cancer spectrum may be interested in this topic, from newly-diagnosed patients deciding on a treatment plan, to men with metastatic disease seeking additional treatment options. PCF’s Chief Medical Officer William K. Oh, MD, speaks with two experienced clinicians who are committed to help patients and families understand what these types of testing mean for their care.

Kara Maxwell, MD, PhD (University of Pennsylvania and Corporal Michael Crescenz VA Medical Center) discusses genetic testing.

Jim C. Hu, MD, MPH (Weill Cornell Medicine) discusses biomarker testing and risk stratification.

PCF thanks Veracyte for their generous support

April 25, 2023: Clinical Trials: What to Consider

Time: 4:30 PM Pacific / 7:30 PM Eastern

Clinical trials for prostate cancer play a vital role in getting new treatments into clinical practice. They can offer the potential for life-extending therapy. Patients and families have many questions: Is it safe? What happens during the trial? Can I still see my doctor? Who pays for it? PCF Chief Medical Officer William K. Oh, MD, hosts two leaders in prostate cancer clinical care and research: Isla Garraway, MD, PhD,(UCLA) and Samuel Washington, MD, MAS (UCSF). They’ll explain the process, distinguish fact from fiction, and discuss how clinical trials can better include diverse populations.

March 14, 2023: PSMA PET Imaging: Doctor and Patient Perspectives

Time: 4:30 PM Pacific / 7:30 PM Eastern

PSMA PET is a newer, highly sensitive imaging scan that can detect prostate cancer metastases much earlier, when they are much smaller. Learn when and how PSMA PET is used, what the results mean, what happens during the scan, and more. Dr. Ryan is joined by nuclear medicine expert Dr. Phillip Koo (Banner MD Anderson Cancer Center) as well as Ira and Sharron, a patient and caregiver who will share their experience.

This event is generously supported by

February 21, 2023: Prostate Cancer Disparities: What Men and Families Need to Know

Time: 4:30-5:30 PM Pacific / 7:30-8:30 PM Eastern

Our series addressing prostate cancer disparities continues with two guests who will distill years of research and clinical experience into practical tips. Dr. John Carpten, PhD (USC) is an expert in prostate cancer genetics, and Dr. Stanley Frencher, MD, is a practicing urologist and Medical Director of Surgical Outcomes and Quality at Martin Luther King, Jr. Community Hospital in Los Angeles. You’ll hear how research is shedding new light on the inheritance of prostate cancer, and why families should be proactive and share knowledge of cancer risk. And if you are diagnosed, learn what you need to know to find a treatment that is right for you, and what questions to ask your provider.

February 8, 2023: Prostate Cancer Disparities: Crucial Conversations

Time: 4:30-5:30 PM Pacific / 7:30-8:30 PM Eastern

1 in 6 Black men will be diagnosed with prostate cancer in his lifetime, vs 1 in 8 white men. PCF begins a yearlong effort to raise awareness of prostate cancer early detection and screening among minority communities. Dr. Ryan speaks with two leaders who have dedicated their careers to understanding and reducing health disparities: Dr. Michael LeNoir, MD, of the African American Wellness Project and Dr. Leanne Burnham of Morehouse School of Medicine. Learn about the roots of prostate cancer disparities and ways to empower yourself to keep you and your family safe from cancer.

January 17, 2023: When Your PSA is Rising after Treatment

Time: 4:30-6:00 PM Pacific / 7:30-9:00 PM Eastern

You’ve been through treatment for prostate cancer. Months or years later, you get the news you hoped would never come: your PSA is rising. PCF President and CEO Dr. Charles J. Ryan helps patients navigate this course in his practice as a medical oncologist. His guests will discuss PSA and recurrence from their perspectives as a urologic oncologist (Dr. Ashley Ross of Northwestern Medicine) and a radiation oncologist (Dr. Paul Nguyen of Dana Farber Cancer Institute). Learn about what the numbers mean, testing beyond PSA, and treatment options. Please note that the recordings below focus on post-surgery and post-radiation, respectively, but you may wish to watch both to get a full picture of the topics discussed. 

Read the Q&A here.

December 13, 2022: Sexual Health and Incontinence

Time: 4:30-6:00 PM Pacific / 7:30-9:00 PM Eastern

Changes in urinary and sexual function are two of the most common—and most feared—possible side effects of treatment for localized prostate cancer. Fortunately, there is room for much optimism: there are many excellent options to manage them. Dr. Ryan speaks with urologic surgeon Dr. Sherita King of Augusta University Health and the Medical College of Georgia. She is an expert in male and female sexual dysfunction, and a recognized center of excellence in penile implants. Dr. Lindsay Hampson will discuss management of incontinence. She specializes in genitourinary reconstruction, including complications of surgery and radiation therapy, and is Associate Professor of Urology at UCSF.

October 11, 2022: Shared Decision-Making and Treatment Regret

Time: 4:30-5:30 PM Pacific / 7:30-8:30 PM Eastern

How do you make decisions about prostate cancer treatment? It can be challenging, at any stage in the journey. Medical oncologist Dr. Alicia Morgans (Dana Farber Cancer Institute) discusses the importance of shared decision-making and practical tips on communicating with your healthcare team. Urologist Dr. Matthew Cooperberg (UCSF) will address a related phenomenon, treatment-related regret.

September 20, 2022: Physical and Mental Wellness in Prostate Cancer

Time: 4:30-5:30 PM Pacific / 7:30-8:30 PM Eastern

Dr. Stacey Kenfield (UCSF) discusses Prostate 8: Simple Lifestyle Changes That Work and offers practical ways to incorporate nutrition and exercise into your life. Psychiatrist Dr. Andrew Roth (MSKCC) specializes in caring for patients with genitourinary cancers. He will review the mental health challenges patients commonly face, how to help yourself, and how to start the conversation with your doctor.

This event is generously supported by